Imaging-based adipose biomarkers for predicting clinical outcomes of cancer patients treated with immune checkpoint inhibitors: a systematic review

BACKGROUND: Since the application of Immune checkpoint inhibitors (ICI), the clinical outcome for metastatic cancer has been greatly improved. Nevertheless, treatment response varies in patients, making it urgent to identify patients who will receive clinical benefits after ICI therapy. Adipose body...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Xinyu, Xie, Ye, Liu, Yixuan, Cai, Xinyang, Hong, Lexuan, Yang, Xiaofeng, Zhang, Luyao, Zhang, Manhuai, Zheng, Xinyi, Ning, Kang, Fang, Mengyuan, Tang, Huancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616831/
https://www.ncbi.nlm.nih.gov/pubmed/37916163
http://dx.doi.org/10.3389/fonc.2023.1198723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616831/
https://www.ncbi.nlm.nih.gov/pubmed/37916163
http://dx.doi.org/10.3389/fonc.2023.1198723

Ejemplares similares